Edwards Lifesciences ROE 2010-2024 | EW

Current and historical return on equity (ROE) values for Edwards Lifesciences (EW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Edwards Lifesciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $4.16B $9.61B 53.63%
2024-06-30 $1.47B $7.51B 20.94%
2024-03-31 $1.41B $7.19B 20.89%
2023-12-31 $1.40B $6.72B 21.62%
2023-09-30 $1.43B $6.73B 22.86%
2023-06-30 $1.39B $6.45B 22.66%
2023-03-31 $1.49B $6.06B 24.78%
2022-12-31 $1.52B $5.81B 25.56%
2022-09-30 $1.46B $6.22B 24.48%
2022-06-30 $1.46B $5.94B 25.12%
2022-03-31 $1.54B $5.85B 27.54%
2021-12-31 $1.50B $5.84B 28.40%
2021-09-30 $1.48B $5.54B 29.70%
2021-06-30 $1.46B $5.13B 31.50%
2021-03-31 $0.85B $4.66B 19.70%
2020-12-31 $0.82B $4.57B 19.95%
2020-09-30 $0.79B $4.21B 19.73%
2020-06-30 $0.74B $3.84B 18.95%
2020-03-31 $1.11B $3.90B 28.85%
2019-12-31 $1.05B $4.15B 28.09%
2019-09-30 $0.77B $3.82B 22.27%
2019-06-30 $0.73B $3.50B 21.56%
2019-03-31 $0.77B $3.45B 23.37%
2018-12-31 $0.72B $3.14B 22.40%
2018-09-30 $0.71B $3.36B 22.41%
2018-06-30 $0.66B $3.16B 20.98%
2018-03-31 $0.56B $3.25B 18.20%
2017-12-31 $0.58B $2.96B 19.76%
2017-09-30 $0.75B $3.16B 25.99%
2017-06-30 $0.72B $2.94B 26.05%
2017-03-31 $0.66B $2.74B 24.97%
2016-12-31 $0.57B $2.62B 22.62%
2016-09-30 $0.55B $2.69B 22.16%
2016-06-30 $0.53B $2.47B 21.83%
2016-03-31 $0.52B $2.30B 21.66%
2015-12-31 $0.50B $2.50B 21.00%
2015-09-30 $0.46B $2.42B 20.32%
2015-06-30 $0.44B $2.29B 20.14%
2015-03-31 $0.87B $2.21B 41.80%
2014-12-31 $0.81B $2.19B 43.31%
2014-09-30 $0.78B $2.04B 45.42%
2014-06-30 $0.76B $1.92B 48.68%
2014-03-31 $0.31B $1.34B 20.67%
2013-12-31 $0.39B $1.54B 25.29%
2013-09-30 $0.40B $1.44B 26.48%
2013-06-30 $0.40B $1.58B 25.54%
2013-03-31 $0.37B $1.59B 24.50%
2012-12-31 $0.29B $1.48B 19.93%
2012-09-30 $0.27B $1.54B 18.60%
2012-06-30 $0.25B $1.44B 17.98%
2012-03-31 $0.24B $1.39B 17.41%
2011-12-31 $0.24B $1.34B 17.44%
2011-09-30 $0.24B $1.36B 17.68%
2011-06-30 $0.24B $1.39B 17.79%
2011-03-31 $0.24B $1.36B 18.73%
2010-12-31 $0.22B $1.31B 18.20%
2010-09-30 $0.20B $1.23B 17.33%
2010-06-30 $0.23B $1.12B 20.19%
2010-03-31 $0.22B $1.15B 19.80%
2009-12-31 $0.23B $1.16B 22.03%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.599B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.706B 24.73
Intuitive Surgical (ISRG) United States $193.352B 101.09
Alcon (ALC) Switzerland $43.519B 29.12
IQVIA Holdings (IQV) United States $36.625B 20.18
IDEXX Laboratories (IDXX) United States $35.273B 41.54
DexCom (DXCM) United States $30.978B 46.65
Waters (WAT) United States $22.985B 33.99
STERIS (STE) Ireland $21.603B 24.87
SONOVA HOLDING (SONVY) Switzerland $20.257B 0.00
Hologic (HOLX) United States $17.928B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.368B 13.72
Sysmex ADR (SSMXY) Japan $13.192B 41.37
Globus Medical (GMED) United States $11.424B 28.93
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.192B 44.48
Teleflex (TFX) United States $9.024B 14.39
Glaukos (GKOS) United States $7.669B 0.00
PROCEPT BioRobotics (PRCT) United States $5.015B 0.00
Integer Holdings (ITGR) United States $4.655B 26.38
Veracyte (VCYT) United States $3.419B 102.61
Inari Medical (NARI) United States $3.051B 0.00
TransMedics (TMDX) United States $2.857B 90.57
LivaNova (LIVN) United Kingdom $2.839B 16.39
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.209B 19.86
Tandem Diabetes Care (TNDM) United States $2.135B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.848B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Pulse Biosciences (PLSE) United States $1.284B 0.00
Artivion (AORT) United States $1.242B 82.28
OPKO Health (OPK) United States $1.044B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.901B 15.31
Paragon 28 (FNA) United States $0.864B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.738B 0.00
IRadimed (IRMD) United States $0.682B 36.87
Mesa Laboratories (MLAB) United States $0.660B 15.55
AxoGen (AXGN) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.561B 0.00
Treace Medical Concepts (TMCI) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Semler Scientific (SMLR) United States $0.503B 29.61
Tactile Systems Technology (TCMD) United States $0.446B 24.14
Delcath Systems (DCTH) United States $0.404B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.241B 0.00
Accuray (ARAY) United States $0.216B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.160B 0.00
Sensus Healthcare (SRTS) United States $0.140B 15.02
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.100B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.088B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
Lucid Diagnostics (LUCD) United States $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00